Con la participación de Lilyana Amezcua, MD Las diversas formas en que la EM impacta a la comunidad hispana son temas importantes para discutir. Este seminario web explorará cómo la […]
Read News ArticleSearch Results for:
What You Need to Know About COVID-19 and MS – Program 7
Featuring Barry Hendin, MD and Carrie Hersh, DO, MSc Recorded on October 19, 2020, this seventh installment of our ongoing webinar series provides the latest news and updates at the […]
Read News ArticleLosing Connection: Difficult Discussions in a Virtual World
Featuring Mitzi Joi Williams, MD, Gavin Giovannoni, MBBCh, PhD, FCP, and Patient Advocate, Stanca Presented by two leading MS expert neurologists along with an MS patient advocate, this archived digital […]
Read News ArticleVaccination Safety in MS – Download PDF
– or – No thank you – download file only
Read News ArticleDr. Adam Kaplin’s ABC’s for Good Mental and Emotional Health
A = Ask for Assistance Knowing when and how to ask for help is far more important than knowing how to silently endure being in pain. It actually takes more […]
Read News ArticleUp Front: Needs of the MS Community Are Greater than Ever
Gina Ross Murdoch By Gina Ross Murdoch MSAA President and CEO In the previous issue of The Motivator, I talked about how life had turned upside-down for virtually everyone in […]
Read News ArticleThe Effects of the Pandemic on Individuals with MS
By Miriam Franco, PsyD MSCS Psychotherapist and Psychoanalyst An esteemed member of MSAA’s Healthcare Advisory Council for many years, Dr. Miriam Franco is a psychotherapist and psychoanalyst who specializes in […]
Read News ArticleAsk the Doctor: Viruses and Antibodies
Dr. Barry A. Hendin By Dr. Barry A. Hendin MSAA’s Chief Medical Officer Q: There is a lot of talk about antibodies for COVID-19 after a person has already contracted […]
Read News ArticleResearch News
FDA Approves Kesimpta® (Ofatumumab) for Relapsing Forms of MS On August 20, 2020, Novartis announced that the United States Food and Drug Administration (FDA) approved Kesimpta® (ofatumumab) for adults with relapsing […]
Read News ArticleProgram Notes: MSAA Expands Services and Support During the Pandemic
By Peter Damiri Expanded Core Services As you may have read in previous online announcements, MSAA made several revisions to our core signature services in response to the coronavirus pandemic […]
Read News Article